top of page

Korea Brain Research Institute Signs MOU with Neudive Co., Ltd. for Development of Digital Therapeutic Devices for Brain Developmental Diseases

  • Jul 6
  • 1 min read


The Korea Brain Research Institute signed a business agreement with Neudive Co., Ltd., a company specializing in the development of digital therapeutics, on the 10th at the Korea Brain Research Institute in Dong-gu, Daegu, for 'Mechanism Research and Medical Device Development of Digital Therapeutics for Brain Developmental Diseases.'


The Korea Brain Research Institute and Neudive Co., Ltd. will join forces in the areas of pathogenic mechanism research for overcoming brain diseases, development of digital therapeutic devices, sharing of research infrastructure, and exchange of brain research specialists.


Through this agreement, the two institutions will pursue joint research including: ▷ Development of digital therapeutic biomarkers for brain developmental diseases and clinical application research ▷ Evaluation of the mechanisms of action of digital therapeutic devices for brain developmental diseases and collaboration on building a therapeutic research cohort.


Korea Brain Research Institute Director Pan-gil Suh stated: "Digital therapeutics, which can complement the limitations of drug treatment in developmental diseases such as Autism Spectrum Disorder, is already a rapidly growing field in the United States and other countries. We will build a close cooperative relationship with Neudive and put greater effort into research aimed at overcoming brain diseases."


 
 
bottom of page